Syndax Pharmaceuticals, Inc.
SNDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$319 | -$209 | -$149 | $25 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $43 | $31 | $16 | $13 |
| Change in WC | $13 | $32 | $2 | -$10 |
| Other Non-Cash | -$12 | -$14 | -$2 | $0 |
| Operating Cash Flow | -$275 | -$161 | -$134 | $29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$557 | -$355 | -$495 | -$295 |
| Inv. Sales/Matur. | $337 | $472 | $309 | $254 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | -$220 | $118 | -$186 | -$41 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$21 | $0 |
| Stock Issued | $10 | $258 | $181 | $86 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $344 | $6 | $12 | $32 |
| Financing Cash Flow | $353 | $264 | $172 | $118 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$141 | $221 | -$148 | $107 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $296 | $74 | $222 | $115 |
| End Cash | $154 | $296 | $74 | $222 |
| Free Cash Flow | -$275 | -$161 | -$134 | $29 |